Want to join the conversation?
Analyst Bryan Keane asks $GPN about Europe's performance going forward. CFO Cameron Bready says the company expects Europe to grow in high single digits on an organic basis. $GPN also expects its Erste joint venture to add inorganic growth to revenue expectations in 2017.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?